Oracle provided a profit and revenue outlook that missed estimates, and crucially said spending would rise by $15 billion compared with earlier estimates - a sign that big capital outlays to chase AI ...
Hemab Therapeutics, a clinical-stage biotechnology company developing novel prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders, today announced positive results from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback